Mr. Stanton J. Rowe is CEO of the Nidus Biomedical, a medical device incubator innovating new medical products and procedures. Mr. Rowe was the CEO of NXT Biomedical, the predicate incubator to Nidus Biomedical. Mr. Rowe was previously the Chief Scientific Officer of Edwards Lifesciences Corp. since 2008 and served as its Corporate Vice President of Advanced Technology. Mr. Rowe served as the President and Chief Executive Officer of Percutaneous Valve Technologies Inc. (PVT). This company developed the first TAVR device, sold to Edwards in 2004.